Brochure: Integrated bioprocessing
Posted: 1 April 2021 | Merck | No comments yet
The journey from large molecule to approved biotherapeutic is long, costly, complex, and fraught with risk – yet rewards for success are substantial.
Knowing what to expect and who and where to go for guidance can provide confidence, you’re on the right track and accelerate the journey. From bench to full-scale production, we offer a full range of raw materials, tools, services, and technologies, from off-the-shelf to customizable, to accelerate development, optimization and scale-up of your process. Our in-house experts have decades of bioprocessing experience and will collaborate with you to tackle any development and processing challenge, as well as provide guidance on regulatory expectations and testing requirements to meet your compliance needs.
Related content from this organisation
- MSD set to acquire novel antibody for B-cell malignancies
- Novel immunotherapy combination approved for endometrial cancer
- Innovating small molecule injectables: market forecast to 2033
- Ophthalmology acquisition to advance tri-specific antibody
- Antibody-immunotherapy treatment shows benefit in serious endometrial cancer
Related topics
Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Chromatography, Excipients, Formulation, Gene therapy, Good Manufacturing Practice (GMP), Manufacturing, Outsourcing
